Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04995055 · ClinicalTrials.gov registry record · NA
Evaluation of Multifocal Contact Lens Designs With and Without an HEV Blocker on Visual Function
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT04995055 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 37 participants.
The verdict
NCT04995055, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
This is a single-masked, bilateral, controlled, randomized, 2x2 crossover, non-dispensing clinical trial to characterize the effects of an HEV-Blocker on several measures of visual function in a presbyopic population.
Interventions
- DEVICE ACUVUE® OASYS Multifocal
- DEVICE JJVC Investigational Multifocal Contact Lens TEST Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2022-04-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04995055
The ClinicalTrials.gov registry entry for NCT04995055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ACUVUE® OASYS Multifocal is the first listed.
NCT04995055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04995055 about?
NCT04995055 is a clinical study titled "Evaluation of Multifocal Contact Lens Designs With and Without an HEV Blocker on Visual Function". This is a single-masked, bilateral, controlled, randomized, 2x2 crossover, non-dispensing clinical trial to characterize the effects of an HEV-Blocker on several measures of visual function in a presbyopic population.
What is the current status of trial NCT04995055?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2021-10-25. Estimated completion is 2022-04-14.
What interventions are being tested in trial NCT04995055?
The interventions under investigation include: ACUVUE® OASYS Multifocal (DEVICE), JJVC Investigational Multifocal Contact Lens TEST Lens (DEVICE).
Who is sponsoring clinical trial NCT04995055?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.